The human complement inhibitor Sushi Domain-Containing Protein 4 (SUSD4) expression in tumor cells and infiltrating T cells is associated with better prognosis of breast cancer patients

被引:16
作者
Englund, Emelie [1 ]
Reitsma, Bart [1 ]
King, Ben C. [1 ]
Escudero-Esparza, Astrid [1 ]
Owen, Sioned [2 ]
Orimo, Akira [3 ]
Okroj, Marcin [1 ,4 ]
Anagnostaki, Lola [5 ]
Jiang, Wen G. [2 ]
Jirstrom, Karin [6 ]
Blom, Anna M. [1 ]
机构
[1] Lund Univ, Dept Translat Med, Div Med Prot Chem, S-20502 Malmo, Sweden
[2] Cardiff Univ, CCMRC, Sch Med, Cardiff CF10 3AX, S Glam, Wales
[3] Juntendo Univ, Sch Med, Dept Pathol & Oncol, Tokyo 113, Japan
[4] Med Univ Gdansk, Dept Med Biotechnol, Intercollegiate Fac Biotechnol UG MUG, PL-80210 Gdansk, Poland
[5] Skane Univ Hosp, Dept Clin Pathol, Malmo, Sweden
[6] Lund Univ, Dept Clin Sci Lund, Div Oncol & Pathol, Lund, Sweden
基金
瑞典研究理事会;
关键词
Breast cancer; Cell migration; Complement inhibitor; Immunity; FACTOR-I; RESISTANCE; CARCINOMA; SURVIVAL; PREDICT; GROWTH; BETA;
D O I
10.1186/s12885-015-1734-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The human Sushi Domain-Containing Protein 4 (SUSD4) was recently shown to function as a novel inhibitor of the complement system, but its role in tumor progression is unknown. Methods: Using immunohistochemistry and quantitative PCR, we investigated SUSD4 expression in breast cancer tissue samples from two cohorts. The effect of SUSD4 expression on cell migration and invasion was studied in vitro using two human breast cancer cell lines overexpressing SUSD4. Results: Tissue stainings revealed that both tumor cells and tumor-infiltrating cells expressed SUSD4. The highest SUSD4 expression was detected in differentiated tumors with decreased rate of metastasis, and SUSD4 expression was associated with improved survival of the patients. Moreover, forced SUSD4 expression in human breast cancer cells attenuated their migratory and invasive traits in culture. SUSD4 expression also inhibited colony formation of human breast cancer cells cultured on carcinoma-associated fibroblasts. Furthermore, large numbers of SUSD4-expressing T cells in the tumor stroma associated with better overall survival of the breast cancer patients. Conclusion: Our findings indicate that SUSD4 expression in both breast cancer cells and T cells infiltrating the tumor-associated stroma is useful to predict better prognosis of breast cancer patients.
引用
收藏
页数:13
相关论文
共 21 条
[1]   CD46, a new costimulatory molecule for T cells, that induces p120CBL and LAT phosphorylation [J].
Astier, A ;
Trescol-Biémont, MC ;
Azocar, O ;
Lamouille, B ;
Rabourdin-Combe, C .
JOURNAL OF IMMUNOLOGY, 2000, 164 (12) :6091-6095
[2]   Oestrogen receptors α and β show different associations to clinicopathological parameters and their co-expression might predict a better response to endocrine treatment in breast cancer [J].
Borgquist, S. ;
Holm, C. ;
Stendahl, M. ;
Anagnostaki, L. ;
Landberg, G. ;
Jirstrom, K. .
JOURNAL OF CLINICAL PATHOLOGY, 2008, 61 (02) :197-202
[3]   Complement resistance of human carcinoma cells depends on membrane regulatory proteins, protein kinases and sialic acid [J].
Donin, N ;
Jurianz, K ;
Ziporen, L ;
Schultz, S ;
Kirschfink, M ;
Fishelson, Z .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2003, 131 (02) :254-263
[4]   The novel complement inhibitor human CUB and Sushi multiple domains 1 (CSMD1) protein promotes factor I-mediated degradation of C4b and C3b and inhibits the membrane attack complex assembly [J].
Escudero-Esparza, Astrid ;
Kalchishkova, Nikolina ;
Kurbasic, Emila ;
Jiang, Wen G. ;
Blom, Anna M. .
FASEB JOURNAL, 2013, 27 (12) :5083-5093
[5]   CD4+ follicular helper T cell infiltration predicts breast cancer survival [J].
Gu-Trantien, Chunyan ;
Loi, Sherene ;
Garaud, Soizic ;
Equeter, Carole ;
Libin, Myriam ;
de Wind, Alexandre ;
Ravoet, Marie ;
Le Buanec, Helene ;
Sibille, Catherine ;
Manfouo-Foutsop, Germain ;
Veys, Isabelle ;
Haibe-Kains, Benjamin ;
Singhal, Sandeep K. ;
Michiels, Stefan ;
Rothe, Francoise ;
Salgado, Roberto ;
Duvillier, Hugues ;
Ignatiadis, Michail ;
Desmedt, Christine ;
Bron, Dominique ;
Larsimont, Denis ;
Piccart, Martine ;
Sotiriou, Christos ;
Willard-Gallo, Karen .
JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (07) :2873-2892
[6]   Sushi domain-containing protein 4 (SUSD4) inhibits complement by disrupting the formation of the classical C3 convertase [J].
Holmquist, Emelie ;
Okroj, Marcin ;
Nodin, Bjorn ;
Jirstrom, Karin ;
Blom, Anna M. .
FASEB JOURNAL, 2013, 27 (06) :2355-2366
[7]   Tuberin and hamartin are aberrantly expressed and linked to clinical outcome in human breast cancer:: The role of promoter methylation of TSC genes [J].
Jiang, WG ;
Sampson, J ;
Martin, TA ;
Lee-Jones, L ;
Watkins, G ;
Douglas-Jones, A ;
Mokbel, K ;
Mansel, RE .
EUROPEAN JOURNAL OF CANCER, 2005, 41 (11) :1628-1636
[8]   Complement resistance of tumor cells:: Basal and induced mechanisms [J].
Jurianz, K ;
Ziegler, S ;
Garcia-Schüler, H ;
Kraus, S ;
Bohana-Kashtan, O ;
Fishelson, Z ;
Kirschfink, M .
MOLECULAR IMMUNOLOGY, 1999, 36 (13-14) :929-939
[9]   Autocrine TGF-β and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts [J].
Kojima, Yasushi ;
Acar, Ahmet ;
Eaton, Elinor Ng ;
Mellody, Kieran T. ;
Scheel, Christina ;
Ben-Porath, Ittai ;
Onder, Tamer T. ;
Wang, Zhigang C. ;
Richardson, Andrea L. ;
Weinberg, Robert A. ;
Orimo, Akira .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (46) :20009-20014
[10]   Tumor-Infiltrating CD8+ Lymphocytes Predict Clinical Outcome in Breast Cancer [J].
Mahmoud, Sahar M. A. ;
Paish, Emma Claire ;
Powe, Desmond G. ;
Macmillan, R. Douglas ;
Grainge, Matthew J. ;
Lee, Andrew H. S. ;
Ellis, Ian O. ;
Green, Andrew R. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15) :1949-1955